Cancer therapies based on reactive oxygen species (ROS) have emerged as promising clinical treatments.
Introduction
Intracellular chemical detection can provide a deep understanding of cellular biological processes, and then dene human healthy and diseased states.
1 Besides, intracellular measurements could improve a variety of applications, including drug testing, toxicology, and basic cell biology.
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Telomerase is a ribonucleoprotein reverse transcriptase, which can extend the ends of telomeres to maintain the integrity of the process of chromosome replication. The activity of telomerase is inhibited in normal cells and is activated in cancer cells. This characteristic of telomerase makes it an important biomarker in the early diagnosis, prediction and treatment of cancer.
3 In view of this, a high sensitivity method of intracellular telomerase activity detection is signicant for disease mechanism research and clinical diagnosis. Electrochemiluminescence (ECL), as a highly sensitive detection technique, combines the advantages of both electrochemical and chemiluminescence methods and has attracted considerable attention in the eld of clinical diagnosis and biomolecular detection. 5 Luminol has been widely used in biosensor detection as a traditional ECL active material. 6 Early reports have shown that some metal nanoparticles (Au NPs or Pt NPs) can form stable inorganic-organic complex lms with polyluminol under certain conditions and that the composite lms exhibit a highly sensitive analytical property for the detection of analytes.
7 However, previously reported ECL works on telomerase detection mainly needed to extract telomerase from cells and detected the extracted telomerase activity, 8 and the required process of extraction, preparation and storage of telomerase can probably inuence the original activity of the telomerase and is expected to impact the nal testing results. In view of this, an in situ method for detection of intracellular telomerase activity with high sensitivity is signicant for studies of disease mechanism and clinical diagnosis. In this work we rst used electrodeposited polyluminol-Pt NPs for in situ intracellular telomerase detection, which avoids the previously required extraction of telomerase from cells. Reactive oxygen species (ROS) including hydroxyl radicals (cOH), superoxide anions (O 2 c), hydrogen peroxide (H 2 O 2 ), etc., which serve dual roles in the cell life cycle, function as second messengers for several growth factors, cytokines, and signal transduction.
9
Disrupting the balance of the ROS level could kill cells by causing oxidative damage to their lipids, protein, and DNA. Recent studies have reported a cancer treatment by ROS which has been widely adopted for clinical applications.
10 Among ROS, H 2 O 2 is the most stable species and has captured the interest of many researchers due to its easy assay by a variety of methods, including colorimetry, electrochemical methods, chemiluminescence and uorescence.
11
Therefore, based on the excellent ECL properties of polyluminol-Pt NPs composite lms and the properties of ROS, a new method for monitoring intracellular telomerase activity and a targeted therapy of HL-60 cancer cells were designed (Scheme 1). Firstly, polyluminol-Pt NPs composite lms modied with aptamer on the ITO electrode were used as a detection platform. Mesoporous silica nanoparticles (MSNs) lled with phorbol 12-myristate 13-acetate (PMA) and closed with T-primer DNA and aptamer DNA were used to recognize the HL-60 cancer cells, induce ECL signals and kill the HL-60 cancer cells. Aer MSN@PMA was endocytosed into the HL-60 cancer cells, T-primer DNA could be extended by telomerase and formed a hairpin-like DNA structure which dropped out of the MSN@PMA surface. PMA was then released and stimulated the HL-60 cancer cells to produce ROS. Furthermore, the released ROS could cause DNA oxidative cleavage reactions on the MSN surface and release more PMA which brought about the cyclic and amplied production of more ROS. The intracellular telomerase activity of the HL-60 cancer cells increased from 15 to 9000 and was monitored according to the generated ECL intensity of polyluminol-Pt NPs. Furthermore, the HL-60 cancer cell could be killed by ROS with high efficacy. Finally, the challenges of producing a simple, specic, sensitive technique for intracellular telomerase activity analysis and HL-60 cancer cell therapy by ECL technology and ROS were achieved.
Results and discussion
In the study, electrodeposition technology was used to build a detection platform. Aer the ITO chip was fabricated, H 2 PtCl 6 and luminol could form stable polyluminol-Pt NPs composite lms on the working part of the ITO chip by electrodeposition.
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SEM images of the polyluminol-Pt NPs electrodeposited with different concentrations of H 2 PtCl 6 are shown in Fig. 1 . These images show the particle size of the polyluminol-Pt NPs decreasing with decreasing concentrations of H 2 PtCl 6 solution. The dispersions of the polyluminol-Pt NPs ( Fig. 1A and B ) with high H 2 PtCl 6 concentrations were sparse while the dispersions of the polyluminol-Pt NPs ( Fig. 1C and D) with low concentrations of H 2 PtCl 6 tended to be smaller and more compact. The characterization above demonstrates that polyluminol-Pt NPs electrodeposited with lower concentrations of H 2 PtCl 6 solution have larger specic surface areas and tend to be more stable. In addition, the ECL intensity of the polyluminol-Pt NPs gradually increased with decreasing concentrations of H 2 PtCl 6 solution (Fig. 1E ). This phenomenon may be attributed to the smaller polyluminol-Pt NPs having higher specic surface areas and catalytic ability. However, the polyluminol-Pt NPs composite lm became unstable when the concentration of H 2 PtCl 6 was higher than 0.5 mM. Therefore, considering its preferable stability and ECL intensity, polyluminol-Pt NPs composite lm was constructed when the concentration of H 2 PtCl 6 was 0.5 mM, and the electrodeposition was nally carried out with the potential scanning from À0.2 to 1.2 V for 50 cycles at a scan rate of 0.1 V s À1 . As shown in Fig. 1F , the ECL measurements of the fabricated polyluminol-Pt NPs composite lm showed stable and high ECL signals, which suggest that the polyluminol-Pt NPs composite lm is an excellent platform to monitor intracellular telomerase activity. The principle of monitoring intracellular telomerase activity based on polyluminol-Pt NPs composite lms is shown in Scheme 1. MSNs, which have unique characteristics, including an easily modiable functional surface, good biocompatibility and effective load treatment agentia, are widely used in the construction of multifunctional drug carriers. 13 Here, MSNs were chosen and synthesized as PMA carriers due to their properties of low density and a high specic surface area.
14 The results of dynamic light scattering (DLS) displayed in ESI Fig. S1 † show an average diameter of 180 nm for the MSNs. TEM images also reect that the synthesized MSNs show great distribution and uniform size, with an average diameter of around 180 nm (Fig. 2A) . The holes on the MSNs are clearly bright which means that the mesoporous structure was successfully synthesized. However, aer the MSNs were lled with PMA and closed by DNA, the holes on the MSNs become darker which means that the holes on the MSNs were successfully closed by DNA (Fig. 2B) . The same result was also proven by the zeta potential which was shown in ESI Fig. S2 . † On the basis of the different charges of the compounds, we can conclude that the positive charge of APTES-MSN could combine with the negatively charged T-primer DNA and nally formed the negative charge of the T-primer DNA@APTES-MSN due to electrostatic attraction. Aer successfully synthesizing the MSN@PMA probe, endocytosis between the HL-60 cancer cells and the MSN@PMA probe was proven by the confocal microscopic images shown in Fig. S3A . † Fluorescence imaging indicated the apparent internalization of the MSN@PMA probes by the HL-60 cancer cells. Aer the endocytosis reaction, a gel electrophoresis experiment was carried out to prove the feasibility of the extension of T-primer DNA by telomerase. Fig. S3B † shows an obvious 70 bp band of the extension products of Tprimer DNA (lane C), which is longer than that of the Tprimer DNA without extension (lane B), and the result indicates the successful extension of T-primer DNA by telomerase. Also, the T-primer DNA extension reaction by heated telomerase displays no band of extension products which means the telomerase is inactivated by heating (lane D). From the above results, MSN-PMA closed with aptamer and T-primer DNA could be endocytosed into the HL-60 cancer cells and T-primer DNA could be extended and formed the hairpin-like DNA structure in the presence of telomerase. Then, the extended DNA dropped out of the MSN probe surface and the released PMA could stimulate the HL-60 cancer cells to produce ROS. The released hydrogen peroxide generated ECL signal of the polyluminol-Pt NPs composite lms and the ROS could cause apoptosis of the HL-60 cancer cells aer detection. The challenge of creating a simple and specic intracellular monitoring and therapy integrated ECL technique was accomplished.
In order to get the optimized detection result, the incubation time of MSN@PMA and the HL-60 cancer cells was optimized.
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Fig. S4 † in the ESI shows that the ECL intensities rst gradually increased with increasing incubation time and tended to be stable aer 90 minutes, which means that the reactions were gradually carried out to completion. Finally, 90 minutes was chosen as the optimal incubation time to make sure the action was sufficient for monitoring the intracellular telomerase activity. Aer incubation, MSN@PMA probe stimulated the HL-60 cancer cells to release hydrogen peroxide which generated an ECL signal with the polyluminol-Pt NPs composite lm.
As shown in Fig. 2C , the ECL intensity of the polyluminol-Pt NPs composite lms increased according to the increasing number of HL-60 cancer cells from 15 cells to 11 000 cells. The activity of the intracellular telomerase was then monitored. As shown in Fig. 2D , we can observe that the ECL intensities had a linear relationship with the number of HL-60 cancer cells in the range from 15 to 9000 (R ¼ 0.986) with a detection limit of 15 (S/N ¼ 3). Aptamer modied on ITO chips was used to ensure capture of the HL-60 cancer cells with specicity (Fig. S5 †) , and a controlled experiment indicated a quite satisfying result for the specicity. The ECL intensities of telomerase detection measured in a blank experiment, Romos cells, LO-2 cells, HopG2 cells and HL-60 cancer cells are shown in Fig. S6 . † Obviously the ECL intensity increased substantially only when the HL-60 cancer cells were present. This result indicates that this approach has high specicity for detecting intracellular telomerase in HL-60 cancer cells.
We further studied the cytotoxicity of the MSN@PMA probe in the HL-60 cell line and in the non-cancerous LO-2 cell line by CCK-8 assay. According to the assay data in Fig. 3 it could be concluded that the MSNs have no cytotoxicity to either the LO-2 cells or the HL-60 cancer cells. Also, the MSN@PMA probe has no cytotoxicity to the LO-2 cells. However, aer being treated with the MSN@PMA probe for 12 h, the HL-60 cells viability was less than 30% and diagnosis of HL-60 cancer cells was observable. This phenomenon is probably due to the high activity of telomerase in HL-60 cancer cells and no activity of telomerase in LO-2 cells. The active telomerase could release PMA from the MSN@PMA probe which may result in an immediate increase in the intracellular ROS level. The concept that cancer cells are more vulnerable to increased intracellular ROS levels has spurred numerous design considerations for inducing preferential cancer cell death by ROS-mediated cancer treatments.
The degree of cell membrane damage and the disruption of phosphatidylserine distribution on the cell membranes were revealed by Annexin V-FITC/PI co-staining and a ow cytometry assay, showing 31.4% of the HL-60 cancer cells in an early apoptosis stage aer 12 h incubation with MSN@PMA, signi-cantly higher than those of the control samples (Fig. 4A , and Fig. S7 †, ESI) . It is worth noting that the elevated ROS level may take over and trigger cell apoptosis through the subsequent ROS-mediated mechanism. TUNEL staining further conrmed that HL-60 cancer cells treated with MSN@PMA underwent apoptosis with prominent DNA fragmentation. Aer the phenylindole (PI) staining experiment, we found that HL-60 cancer cells treated with MSNs and LO-2 cells treated with MSNs or the MSN@PMA probe had no shrunken nuclei compared with the control samples (Fig. 4B, and Fig. S8 †, ESI) . However, we found that the cell nuclei signicantly shrank and had shape abnormality compared with the control samples aer the HL-60 cancer cells were treated with the MSN@PMA probe for 12 h (Fig. 4B (c) ). This phenomenon means that MSN@PMA could kill HL-60 cancer cells and be harmless to non-cancerous cells which means that the targeted therapy of cancer cells was successfully achieved here.
Conclusions
In this work, a new intracellular telomerase detection and cancer therapy technology using an ECL method was created utilising the special ECL properties of polyluminol-Pt NPs composite lms and ROS. The ECL intensity produced by polyluminol-Pt NPs composite lms on an ITO electrode was applied to detect the intracellular telomerase activity instead of that of extracted telomerase in HL-60 cells. Aer detection, HL-60 cancer cells could be killed by ROS which were reduced into harmless materials aer therapy. Compared with previous studies, this work provides a brand new method which rst studies the high sensitivity, low cost and intracellular telomerase activity detection by ECL technology, and the integration of detection and targeted therapy makes the method more meaningful for application.
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